Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.08% Nasdaq Down0.11%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS

32.23 Up 0.15(0.47%) 4:00PM EDT|After Hours : 32.23 0.00 (0.00%) 4:37PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 71,865   81,472   77,438   75,656  
Cost of Revenue13,643  16,363  14,921  13,734  
Gross Profit 58,222   65,109   62,517   61,922  
Operating Expenses
Research Development12,520  18,191  12,031  12,634  
Selling General and Administrative48,198  45,594  40,121  44,230  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,496) 1,324   10,365   5,058  
Income from Continuing Operations
Total Other Income/Expenses Net173  153  141  123  
Earnings Before Interest And Taxes(2,323)1,477  10,506  5,181  
Interest Expense591  379  379  356  
Income Before Tax(2,914)1,098  10,127  4,825  
Income Tax Expense(1,775)(131,875)533  280  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(1,139)132,973  9,594  4,545  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (1,139) 132,973   9,594   4,545  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (1,139) 132,973   9,594   4,545  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.